# The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

> **NCT04228484** · NA · COMPLETED · sponsor: **University Hospital, Gentofte, Copenhagen** · enrollment: 15 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **OTHER:** Placebo
- **OTHER:** GIP receptor antagonization

## Key facts

- **NCT ID:** NCT04228484
- **Lead sponsor:** University Hospital, Gentofte, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-07
- **Primary completion:** 2021-06-04
- **Final completion:** 2022-10-01
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04228484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04228484, "The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04228484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*